Symbols
Aime
Products
News
Market
Portfolio
Brokers
US Stocks
/
INZY
/
revenue
I
INZY
EPS
Revenue & Expenses
Why did Inozyme Pharma's operating expenses surge in Q2 2024?
Ask Aime more questions
